Author:
Sharma Swati,Bano Ambreen,Gupta Anmol,Bajpai Preeti,Lohani Minaxi,Pathak Neelam
Reference122 articles.
1. Alice, F., Albert, L., Stephanie, N., Iris, C., & Susan, C. (2012). Efficacy and safety of xylooligosaccharides. Dietary Fibre and Health, 497–518.
2. Alvarez-Olmos, M. I., & Oberhelman, R. A. (2001). Probiotic agents and infectious diseases: A modern perspective on a traditional therapy. Clinical Infectious Diseases, 32(11), 1567–1576.
3. Anadón, A., Martínez-Larrañaga, M. R., & Martínez, M. A. (2006). Probiotics for animal nutrition in the European Union. Regulation and safety assessment. Regulatory Toxicology and Pharmacology, 45(1), 91–95.
4. Anukam, K. C., & Reid, G. (2007). Probiotics: 100 years (1907–2007) after Elie Metchnikoff’s observation. Communicating current research and educational topics and trends in applied. Microbiology, 1, 466–474.
5. Arslanoglu, S., Moro, G. E., Schmitt, J., Tandoi, L., Rizzardi, S., & Boehm, G. (2008). Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. The Journal of Nutrition, 138(6), 1091–1095.